| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $655.4M | +8.3% |
| Cost of Revenue | $166.9M | +21.6% |
| Gross Profit | $488.5M | +4.4% |
| R&D Expense | $224.5M | +7.1% |
| SG&A Expense | $177.7M | -6.4% |
| Operating Income | -$153.8M | +9.8% |
| Interest Expense | $22.2M | +90.5% |
| Pre-tax Income | -$136.3M | -3.9% |
| Income Tax | -$23K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.5M | -42.9% |
| Accounts Receivable | $89.4M | +20.5% |
| Inventory | $41.1M | +17.2% |
| Current Assets | $646.7M | -41.6% |
| Total Assets | $804.3M | -35.2% |
| Current Liabilities | $223.2M | -70.5% |
| Long-term Debt | $195.0M | +100.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -85.9% |
| Capital Expenditures | $26.6M | -37.8% |
| Investing Cash Flow | $437.3M | +411.8% |
| Financing Cash Flow | -$451.3M | -599.7% |
| Free Cash Flow | -$75.7M | -9.3% |
| -100.1% |
| Net Income | -$136.2M | +19.2% |
| EPS (Basic) | -$1.22 | +21.8% |
| EPS (Diluted) | -$1.22 | +21.8% |
| Total Liabilities |
| $463.9M |
| -47.3% |
| Stockholders' Equity | $340.5M | -5.5% |